Vivek Naranbhai1, Christina C Chang, Raveshni Durgiah, Saleha Omarjee, Andrew Lim, Mahomed-Yunus S Moosa, Julian H Elliot, Thumbi Ndung'u, Sharon R Lewin, Martyn A French, William H Carr. 1. aCentre for the AIDS Programme of Research in South Africa bHIV Pathogenesis Programme, Nelson R Mandela School of Medicine, University of KwaZulu Natal, Durban, South Africa cNuffield Department of Medicine, University of Oxford, Oxford, UK dDepartment of Infectious Diseases, Monash University and Alfred Hospital eCentre for Biomedical Research, Burnet Institute, Melbourne fSchool of Pathology and Laboratory Medicine, University of Western Australia, Perth, Australia gDepartment of Infectious Diseases, Nelson R Mandela School of Medicine hKwaZulu-Natal Research Institute for Tuberculosis and HIV(K-RITH), University of KwaZulu Natal, Durban, South Africa iMax Planck Institute for Infection Biology, Berlin, Germany jMedgar Evers College (City University of New York), Brooklyn, New York, USA. *Vivek Naranbhai and Christina C. Chang contributed equally to the writing of the article.
Abstract
OBJECTIVE: The role of innate immunity in the pathogenesis of cryptococcal meningitis is unclear. We hypothesized that natural killer (NK) cell and monocyte responses show central nervous system (CNS) compartment-specific profiles, and are altered by antifungal therapy and combination antiretroviral therapy (cART) during cryptococcal meningitis/HIV coinfection. DESIGN: Substudy of a prospective cohort study of adults with cryptococcal meningitis/HIV coinfection in Durban, South Africa. METHODS: We used multiparametric flow cytometry to study compartmentalization of subsets, CD69 (a marker of activation), CXCR3 and CX3CR1 expression, and cytokine secretion of NK cells and monocytes in freshly collected blood and cerebrospinal fluid (CSF) at diagnosis (n = 23), completion of antifungal therapy induction (n = 19), and after a further 4 weeks of cART (n = 9). RESULTS: Relative to blood, CSF was enriched with CD56(bright) (immunoregulatory) NK cells (P = 0.0004). At enrolment, CXCR3 expression was more frequent among blood CD56(bright) than either blood CD56(dim) (P < 0.0001) or CSF CD56(bright) (P = 0.0002) NK cells. Antifungal therapy diminished blood (P < 0.05), but not CSF CXCR3(pos) NK-cell proportions nor CX3CR1(pos) NK-cell proportions. CD56(bright) and CD56(dim) NK cells were more activated in CSF than blood (P < 0.0001). Antifungal therapy induction reduced CD56(dim) NK-cell activation in CSF (P = 0.02). Activation of blood CD56(bright) and CD56(dim) NK cells was diminished following cART commencement (P < 0.0001, P = 0.03). Immunoregulatory NK cells in CSF tended to secrete higher levels of CXCL10 (P = 0.06) and lower levels of tumor necrosis factor α (P = 0.06) than blood immunoregulatory NK cells. CSF was enriched with nonclassical monocytes (P = 0.001), but antifungal therapy restored proportions of classical monocytes (P = 0.007). CONCLUSION: These results highlight CNS activation, trafficking, and function of NK cells and monocytes in cryptococcal meningitis/HIV and implicate immunoregulatory NK cells and proinflammatory monocytes as potential modulators of cryptococcal meningitis pathogenesis during HIV coinfection.
OBJECTIVE: The role of innate immunity in the pathogenesis of cryptococcal meningitis is unclear. We hypothesized that natural killer (NK) cell and monocyte responses show central nervous system (CNS) compartment-specific profiles, and are altered by antifungal therapy and combination antiretroviral therapy (cART) during cryptococcal meningitis/HIV coinfection. DESIGN: Substudy of a prospective cohort study of adults with cryptococcal meningitis/HIV coinfection in Durban, South Africa. METHODS: We used multiparametric flow cytometry to study compartmentalization of subsets, CD69 (a marker of activation), CXCR3 and CX3CR1 expression, and cytokine secretion of NK cells and monocytes in freshly collected blood and cerebrospinal fluid (CSF) at diagnosis (n = 23), completion of antifungal therapy induction (n = 19), and after a further 4 weeks of cART (n = 9). RESULTS: Relative to blood, CSF was enriched with CD56(bright) (immunoregulatory) NK cells (P = 0.0004). At enrolment, CXCR3 expression was more frequent among blood CD56(bright) than either blood CD56(dim) (P < 0.0001) or CSFCD56(bright) (P = 0.0002) NK cells. Antifungal therapy diminished blood (P < 0.05), but not CSFCXCR3(pos) NK-cell proportions nor CX3CR1(pos) NK-cell proportions. CD56(bright) and CD56(dim) NK cells were more activated in CSF than blood (P < 0.0001). Antifungal therapy induction reduced CD56(dim) NK-cell activation in CSF (P = 0.02). Activation of blood CD56(bright) and CD56(dim) NK cells was diminished following cART commencement (P < 0.0001, P = 0.03). Immunoregulatory NK cells in CSF tended to secrete higher levels of CXCL10 (P = 0.06) and lower levels of tumornecrosis factor α (P = 0.06) than blood immunoregulatory NK cells. CSF was enriched with nonclassical monocytes (P = 0.001), but antifungal therapy restored proportions of classical monocytes (P = 0.007). CONCLUSION: These results highlight CNS activation, trafficking, and function of NK cells and monocytes in cryptococcal meningitis/HIV and implicate immunoregulatory NK cells and proinflammatory monocytes as potential modulators of cryptococcal meningitis pathogenesis during HIV coinfection.
Authors: H Le Guillou-Guillemette; G Renier; B Vielle; P Abgueguen; J-M Chennebault; F Lunel; C Payan Journal: Viral Immunol Date: 2006 Impact factor: 2.257
Authors: Christina C Chang; Saleha Omarjee; Andrew Lim; Tim Spelman; Bernadett I Gosnell; William H Carr; Julian H Elliott; Mohamed-Yunus S Moosa; Thumbi Ndung'u; Martyn A French; Sharon R Lewin Journal: J Infect Dis Date: 2013-08-01 Impact factor: 5.226
Authors: Angela L Zhang; Paula Colmenero; Ulrich Purath; Cristina Teixeira de Matos; Wolfgang Hueber; Lars Klareskog; Ingo H Tarner; Edgar G Engleman; Kalle Söderström Journal: Blood Date: 2007-07-12 Impact factor: 22.113
Authors: Marianne Eisenhardt; Andreas Glässner; Benjamin Krämer; Christian Körner; Bernhard Sibbing; Pavlos Kokordelis; Hans Dieter Nischalke; Tilman Sauerbruch; Ulrich Spengler; Jacob Nattermann Journal: PLoS One Date: 2012-07-05 Impact factor: 3.240
Authors: Katlego Sojane; Richard T Kangethe; Christina C Chang; Mahomed-Yunus S Moosa; Sharon R Lewin; Martyn A French; Thumbi Ndung'u Journal: AIDS Res Hum Retroviruses Date: 2018-05-23 Impact factor: 2.205
Authors: Ngomu Akeem Akilimali; Christina C Chang; Daniel M Muema; Tarylee Reddy; Mahomed-Yunus S Moosa; Sharon R Lewin; Martyn A French; Thumbi Ndung'u Journal: Clin Infect Dis Date: 2017-10-16 Impact factor: 9.079
Authors: Anil A Panackal; Simone C Wuest; Yen-Chih Lin; Tianxia Wu; Nannan Zhang; Peter Kosa; Mika Komori; Andrew Blake; Sarah K Browne; Lindsey B Rosen; Ferry Hagen; Jacques Meis; Stuart M Levitz; Martha Quezado; Dima Hammoud; John E Bennett; Bibi Bielekova; Peter R Williamson Journal: PLoS Pathog Date: 2015-05-28 Impact factor: 6.823
Authors: David B Meya; Samuel Okurut; Godfrey Zziwa; Melissa A Rolfes; Melander Kelsey; Steve Cose; Moses Joloba; Prossy Naluyima; Brent E Palmer; Andrew Kambugu; Harriet Mayanja-Kizza; Paul R Bohjanen; Michael A Eller; Sharon M Wahl; David R Boulware; Yuka C Manabe; Edward N Janoff Journal: J Infect Dis Date: 2014-12-09 Impact factor: 5.226